<?xml version="1.0" encoding="utf-8"?>
<uniprot xmlns="http://uniprot.org/uniprot" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://uniprot.org/uniprot http://www.uniprot.org/support/docs/uniprot.xsd">
<entry dataset="Swiss-Prot" created="2001-04-27" modified="2020-10-07" version="210">
<accession>Q14145</accession>
<accession>B3KPD5</accession>
<accession>Q6LEP0</accession>
<accession>Q8WTX1</accession>
<accession>Q9BPY9</accession>
<name>KEAP1_HUMAN</name>
<protein>
<recommendedName>
<fullName evidence="42">Kelch-like ECH-associated protein 1</fullName>
</recommendedName>
<alternativeName>
<fullName evidence="44">Cytosolic inhibitor of Nrf2</fullName>
<shortName evidence="44">INrf2</shortName>
</alternativeName>
<alternativeName>
<fullName evidence="46">Kelch-like protein 19</fullName>
</alternativeName>
</protein>
<gene>
<name type="primary" evidence="42 46">KEAP1</name>
<name type="synonym" evidence="44">INRF2</name>
<name type="synonym" evidence="43">KIAA0132</name>
<name type="synonym" evidence="46">KLHL19</name>
</gene>
<organism>
<name type="scientific">Homo sapiens</name>
<name type="common">Human</name>
<dbReference type="NCBI Taxonomy" id="9606"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Primates</taxon>
<taxon>Haplorrhini</taxon>
<taxon>Catarrhini</taxon>
<taxon>Hominidae</taxon>
<taxon>Homo</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="submission" date="2001-03" db="EMBL/GenBank/DDBJ databases">
<title>Human INrf2 gene structure and nucleotide sequence.</title>
<authorList>
<person name="Dhakshinamoorthy S."/>
<person name="Jaiswal A.K."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA]</scope>
</reference>
<reference key="2">
<citation type="journal article" date="1995" name="DNA Res." volume="2" first="167" last="174">
<title>Prediction of the coding sequences of unidentified human genes. IV. The coding sequences of 40 new genes (KIAA0121-KIAA0160) deduced by analysis of cDNA clones from human cell line KG-1.</title>
<authorList>
<person name="Nagase T."/>
<person name="Seki N."/>
<person name="Tanaka A."/>
<person name="Ishikawa K."/>
<person name="Nomura N."/>
</authorList>
<dbReference type="PubMed" id="8590280"/>
<dbReference type="DOI" id="10.1093/dnares/2.4.167"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]</scope>
<scope>VARIANT ASN-349</scope>
<source>
<tissue>Bone marrow</tissue>
</source>
</reference>
<reference key="3">
<citation type="submission" date="2008-12" db="EMBL/GenBank/DDBJ databases">
<authorList>
<person name="Ohara O."/>
<person name="Nagase T."/>
<person name="Kikuno R."/>
<person name="Nomura N."/>
</authorList>
</citation>
<scope>SEQUENCE REVISION</scope>
</reference>
<reference key="4">
<citation type="journal article" date="2004" name="Nat. Genet." volume="36" first="40" last="45">
<title>Complete sequencing and characterization of 21,243 full-length human cDNAs.</title>
<authorList>
<person name="Ota T."/>
<person name="Suzuki Y."/>
<person name="Nishikawa T."/>
<person name="Otsuki T."/>
<person name="Sugiyama T."/>
<person name="Irie R."/>
<person name="Wakamatsu A."/>
<person name="Hayashi K."/>
<person name="Sato H."/>
<person name="Nagai K."/>
<person name="Kimura K."/>
<person name="Makita H."/>
<person name="Sekine M."/>
<person name="Obayashi M."/>
<person name="Nishi T."/>
<person name="Shibahara T."/>
<person name="Tanaka T."/>
<person name="Ishii S."/>
<person name="Yamamoto J."/>
<person name="Saito K."/>
<person name="Kawai Y."/>
<person name="Isono Y."/>
<person name="Nakamura Y."/>
<person name="Nagahari K."/>
<person name="Murakami K."/>
<person name="Yasuda T."/>
<person name="Iwayanagi T."/>
<person name="Wagatsuma M."/>
<person name="Shiratori A."/>
<person name="Sudo H."/>
<person name="Hosoiri T."/>
<person name="Kaku Y."/>
<person name="Kodaira H."/>
<person name="Kondo H."/>
<person name="Sugawara M."/>
<person name="Takahashi M."/>
<person name="Kanda K."/>
<person name="Yokoi T."/>
<person name="Furuya T."/>
<person name="Kikkawa E."/>
<person name="Omura Y."/>
<person name="Abe K."/>
<person name="Kamihara K."/>
<person name="Katsuta N."/>
<person name="Sato K."/>
<person name="Tanikawa M."/>
<person name="Yamazaki M."/>
<person name="Ninomiya K."/>
<person name="Ishibashi T."/>
<person name="Yamashita H."/>
<person name="Murakawa K."/>
<person name="Fujimori K."/>
<person name="Tanai H."/>
<person name="Kimata M."/>
<person name="Watanabe M."/>
<person name="Hiraoka S."/>
<person name="Chiba Y."/>
<person name="Ishida S."/>
<person name="Ono Y."/>
<person name="Takiguchi S."/>
<person name="Watanabe S."/>
<person name="Yosida M."/>
<person name="Hotuta T."/>
<person name="Kusano J."/>
<person name="Kanehori K."/>
<person name="Takahashi-Fujii A."/>
<person name="Hara H."/>
<person name="Tanase T.-O."/>
<person name="Nomura Y."/>
<person name="Togiya S."/>
<person name="Komai F."/>
<person name="Hara R."/>
<person name="Takeuchi K."/>
<person name="Arita M."/>
<person name="Imose N."/>
<person name="Musashino K."/>
<person name="Yuuki H."/>
<person name="Oshima A."/>
<person name="Sasaki N."/>
<person name="Aotsuka S."/>
<person name="Yoshikawa Y."/>
<person name="Matsunawa H."/>
<person name="Ichihara T."/>
<person name="Shiohata N."/>
<person name="Sano S."/>
<person name="Moriya S."/>
<person name="Momiyama H."/>
<person name="Satoh N."/>
<person name="Takami S."/>
<person name="Terashima Y."/>
<person name="Suzuki O."/>
<person name="Nakagawa S."/>
<person name="Senoh A."/>
<person name="Mizoguchi H."/>
<person name="Goto Y."/>
<person name="Shimizu F."/>
<person name="Wakebe H."/>
<person name="Hishigaki H."/>
<person name="Watanabe T."/>
<person name="Sugiyama A."/>
<person name="Takemoto M."/>
<person name="Kawakami B."/>
<person name="Yamazaki M."/>
<person name="Watanabe K."/>
<person name="Kumagai A."/>
<person name="Itakura S."/>
<person name="Fukuzumi Y."/>
<person name="Fujimori Y."/>
<person name="Komiyama M."/>
<person name="Tashiro H."/>
<person name="Tanigami A."/>
<person name="Fujiwara T."/>
<person name="Ono T."/>
<person name="Yamada K."/>
<person name="Fujii Y."/>
<person name="Ozaki K."/>
<person name="Hirao M."/>
<person name="Ohmori Y."/>
<person name="Kawabata A."/>
<person name="Hikiji T."/>
<person name="Kobatake N."/>
<person name="Inagaki H."/>
<person name="Ikema Y."/>
<person name="Okamoto S."/>
<person name="Okitani R."/>
<person name="Kawakami T."/>
<person name="Noguchi S."/>
<person name="Itoh T."/>
<person name="Shigeta K."/>
<person name="Senba T."/>
<person name="Matsumura K."/>
<person name="Nakajima Y."/>
<person name="Mizuno T."/>
<person name="Morinaga M."/>
<person name="Sasaki M."/>
<person name="Togashi T."/>
<person name="Oyama M."/>
<person name="Hata H."/>
<person name="Watanabe M."/>
<person name="Komatsu T."/>
<person name="Mizushima-Sugano J."/>
<person name="Satoh T."/>
<person name="Shirai Y."/>
<person name="Takahashi Y."/>
<person name="Nakagawa K."/>
<person name="Okumura K."/>
<person name="Nagase T."/>
<person name="Nomura N."/>
<person name="Kikuchi H."/>
<person name="Masuho Y."/>
<person name="Yamashita R."/>
<person name="Nakai K."/>
<person name="Yada T."/>
<person name="Nakamura Y."/>
<person name="Ohara O."/>
<person name="Isogai T."/>
<person name="Sugano S."/>
</authorList>
<dbReference type="PubMed" id="14702039"/>
<dbReference type="DOI" id="10.1038/ng1285"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]</scope>
</reference>
<reference key="5">
<citation type="journal article" date="2004" name="Nature" volume="428" first="529" last="535">
<title>The DNA sequence and biology of human chromosome 19.</title>
<authorList>
<person name="Grimwood J."/>
<person name="Gordon L.A."/>
<person name="Olsen A.S."/>
<person name="Terry A."/>
<person name="Schmutz J."/>
<person name="Lamerdin J.E."/>
<person name="Hellsten U."/>
<person name="Goodstein D."/>
<person name="Couronne O."/>
<person name="Tran-Gyamfi M."/>
<person name="Aerts A."/>
<person name="Altherr M."/>
<person name="Ashworth L."/>
<person name="Bajorek E."/>
<person name="Black S."/>
<person name="Branscomb E."/>
<person name="Caenepeel S."/>
<person name="Carrano A.V."/>
<person name="Caoile C."/>
<person name="Chan Y.M."/>
<person name="Christensen M."/>
<person name="Cleland C.A."/>
<person name="Copeland A."/>
<person name="Dalin E."/>
<person name="Dehal P."/>
<person name="Denys M."/>
<person name="Detter J.C."/>
<person name="Escobar J."/>
<person name="Flowers D."/>
<person name="Fotopulos D."/>
<person name="Garcia C."/>
<person name="Georgescu A.M."/>
<person name="Glavina T."/>
<person name="Gomez M."/>
<person name="Gonzales E."/>
<person name="Groza M."/>
<person name="Hammon N."/>
<person name="Hawkins T."/>
<person name="Haydu L."/>
<person name="Ho I."/>
<person name="Huang W."/>
<person name="Israni S."/>
<person name="Jett J."/>
<person name="Kadner K."/>
<person name="Kimball H."/>
<person name="Kobayashi A."/>
<person name="Larionov V."/>
<person name="Leem S.-H."/>
<person name="Lopez F."/>
<person name="Lou Y."/>
<person name="Lowry S."/>
<person name="Malfatti S."/>
<person name="Martinez D."/>
<person name="McCready P.M."/>
<person name="Medina C."/>
<person name="Morgan J."/>
<person name="Nelson K."/>
<person name="Nolan M."/>
<person name="Ovcharenko I."/>
<person name="Pitluck S."/>
<person name="Pollard M."/>
<person name="Popkie A.P."/>
<person name="Predki P."/>
<person name="Quan G."/>
<person name="Ramirez L."/>
<person name="Rash S."/>
<person name="Retterer J."/>
<person name="Rodriguez A."/>
<person name="Rogers S."/>
<person name="Salamov A."/>
<person name="Salazar A."/>
<person name="She X."/>
<person name="Smith D."/>
<person name="Slezak T."/>
<person name="Solovyev V."/>
<person name="Thayer N."/>
<person name="Tice H."/>
<person name="Tsai M."/>
<person name="Ustaszewska A."/>
<person name="Vo N."/>
<person name="Wagner M."/>
<person name="Wheeler J."/>
<person name="Wu K."/>
<person name="Xie G."/>
<person name="Yang J."/>
<person name="Dubchak I."/>
<person name="Furey T.S."/>
<person name="DeJong P."/>
<person name="Dickson M."/>
<person name="Gordon D."/>
<person name="Eichler E.E."/>
<person name="Pennacchio L.A."/>
<person name="Richardson P."/>
<person name="Stubbs L."/>
<person name="Rokhsar D.S."/>
<person name="Myers R.M."/>
<person name="Rubin E.M."/>
<person name="Lucas S.M."/>
</authorList>
<dbReference type="PubMed" id="15057824"/>
<dbReference type="DOI" id="10.1038/nature02399"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
</reference>
<reference key="6">
<citation type="journal article" date="2004" name="Genome Res." volume="14" first="2121" last="2127">
<title>The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).</title>
<authorList>
<consortium name="The MGC Project Team"/>
</authorList>
<dbReference type="PubMed" id="15489334"/>
<dbReference type="DOI" id="10.1101/gr.2596504"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]</scope>
<source>
<tissue>Brain</tissue>
<tissue>Skin</tissue>
<tissue>Uterus</tissue>
</source>
</reference>
<reference key="7">
<citation type="journal article" date="2003" name="Mol. Cell. Biol." volume="23" first="8137" last="8151">
<title>Distinct cysteine residues in Keap1 are required for Keap1-dependent ubiquitination of Nrf2 and for stabilization of Nrf2 by chemopreventive agents and oxidative stress.</title>
<authorList>
<person name="Zhang D.D."/>
<person name="Hannink M."/>
</authorList>
<dbReference type="PubMed" id="14585973"/>
<dbReference type="DOI" id="10.1128/mcb.23.22.8137-8151.2003"/>
</citation>
<scope>FUNCTION</scope>
<scope>MUTAGENESIS OF CYS-151; CYS-273 AND CYS-288</scope>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="8">
<citation type="journal article" date="2004" name="Biochemistry" volume="43" first="12113" last="12122">
<title>Fetal Alz-50 clone 1 interacts with the human orthologue of the Kelch-like Ech-associated protein.</title>
<authorList>
<person name="Strachan G.D."/>
<person name="Morgan K.L."/>
<person name="Otis L.L."/>
<person name="Caltagarone J."/>
<person name="Gittis A."/>
<person name="Bowser R."/>
<person name="Jordan-Sciutto K.L."/>
</authorList>
<dbReference type="PubMed" id="15379550"/>
<dbReference type="DOI" id="10.1021/bi0494166"/>
</citation>
<scope>INTERACTION WITH NFE2L2 AND BPTF</scope>
<scope>FUNCTION</scope>
<scope>TISSUE SPECIFICITY</scope>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="9">
<citation type="journal article" date="2004" name="Mol. Cell. Biol." volume="24" first="10941" last="10953">
<title>Keap1 is a redox-regulated substrate adaptor protein for a Cul3-dependent ubiquitin ligase complex.</title>
<authorList>
<person name="Zhang D.D."/>
<person name="Lo S.-C."/>
<person name="Cross J.V."/>
<person name="Templeton D.J."/>
<person name="Hannink M."/>
</authorList>
<dbReference type="PubMed" id="15572695"/>
<dbReference type="DOI" id="10.1128/mcb.24.24.10941-10953.2004"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH CUL3 AND RBX1</scope>
<scope>MUTAGENESIS OF 125-ILE--GLY-127 AND 162-TYR--ILE-164</scope>
<scope>UBIQUITINATION</scope>
</reference>
<reference key="10">
<citation type="journal article" date="2005" name="J. Biol. Chem." volume="280" first="30091" last="30099">
<title>Ubiquitination of Keap1, a BTB-Kelch substrate adaptor protein for Cul3, targets Keap1 for degradation by a proteasome-independent pathway.</title>
<authorList>
<person name="Zhang D.D."/>
<person name="Lo S.C."/>
<person name="Sun Z."/>
<person name="Habib G.M."/>
<person name="Lieberman M.W."/>
<person name="Hannink M."/>
</authorList>
<dbReference type="PubMed" id="15983046"/>
<dbReference type="DOI" id="10.1074/jbc.m501279200"/>
</citation>
<scope>FUNCTION</scope>
<scope>IDENTIFICATION IN A COMPLEX WITH CUL3 AND RBX1</scope>
<scope>UBIQUITINATION</scope>
<scope>ACTIVITY REGULATION</scope>
<scope>MUTAGENESIS OF CYS-151</scope>
</reference>
<reference key="11">
<citation type="journal article" date="2005" name="Mol. Cell. Biol." volume="25" first="162" last="171">
<title>BTB protein Keap1 targets antioxidant transcription factor Nrf2 for ubiquitination by the Cullin 3-Roc1 ligase.</title>
<authorList>
<person name="Furukawa M."/>
<person name="Xiong Y."/>
</authorList>
<dbReference type="PubMed" id="15601839"/>
<dbReference type="DOI" id="10.1128/mcb.25.1.162-171.2005"/>
</citation>
<scope>FUNCTION</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>IDENTIFICATION IN THE BCR(KEAP1) COMPLEX</scope>
<scope>INTERACTION WITH NFE2L2</scope>
<scope>MUTAGENESIS OF 123-VAL--GLY-127 AND 161-MET-TYR-162</scope>
</reference>
<reference key="12">
<citation type="journal article" date="2005" name="Mol. Cell. Biol." volume="25" first="1089" last="1099">
<title>Nuclear oncoprotein prothymosin alpha is a partner of Keap1: implications for expression of oxidative stress-protecting genes.</title>
<authorList>
<person name="Karapetian R.N."/>
<person name="Evstafieva A.G."/>
<person name="Abaeva I.S."/>
<person name="Chichkova N.V."/>
<person name="Filonov G.S."/>
<person name="Rubtsov Y.P."/>
<person name="Sukhacheva E.A."/>
<person name="Melnikov S.V."/>
<person name="Schneider U."/>
<person name="Wanker E.E."/>
<person name="Vartapetian A.B."/>
</authorList>
<dbReference type="PubMed" id="15657435"/>
<dbReference type="DOI" id="10.1128/mcb.25.3.1089-1099.2005"/>
</citation>
<scope>INTERACTION WITH PTMA</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>MUTAGENESIS OF LEU-308 AND LEU-310</scope>
</reference>
<reference key="13">
<citation type="journal article" date="2009" name="Biochem. J." volume="422" first="171" last="180">
<title>Cul3-mediated Nrf2 ubiquitination and antioxidant response element (ARE) activation are dependent on the partial molar volume at position 151 of Keap1.</title>
<authorList>
<person name="Eggler A.L."/>
<person name="Small E."/>
<person name="Hannink M."/>
<person name="Mesecar A.D."/>
</authorList>
<dbReference type="PubMed" id="19489739"/>
<dbReference type="DOI" id="10.1042/bj20090471"/>
</citation>
<scope>FUNCTION</scope>
<scope>ACTIVITY REGULATION</scope>
<scope>DOMAIN</scope>
<scope>MUTAGENESIS OF CYS-151</scope>
</reference>
<reference key="14">
<citation type="journal article" date="2005" name="Proc. Natl. Acad. Sci. U.S.A." volume="102" first="10070" last="10075">
<title>Modifying specific cysteines of the electrophile-sensing human Keap1 protein is insufficient to disrupt binding to the Nrf2 domain Neh2.</title>
<authorList>
<person name="Eggler A.L."/>
<person name="Liu G."/>
<person name="Pezzuto J.M."/>
<person name="van Breemen R.B."/>
<person name="Mesecar A.D."/>
</authorList>
<dbReference type="PubMed" id="16006525"/>
<dbReference type="DOI" id="10.1073/pnas.0502402102"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH NFE2L2</scope>
</reference>
<reference key="15">
<citation type="journal article" date="2006" name="J. Biol. Chem." volume="281" first="19676" last="19687">
<title>Nrf1 is targeted to the endoplasmic reticulum membrane by an N-terminal transmembrane domain. Inhibition of nuclear translocation and transacting function.</title>
<authorList>
<person name="Wang W."/>
<person name="Chan J.Y."/>
</authorList>
<dbReference type="PubMed" id="16687406"/>
<dbReference type="DOI" id="10.1074/jbc.m602802200"/>
</citation>
<scope>INTERACTION WITH NFE2L1</scope>
</reference>
<reference key="16">
<citation type="journal article" date="2006" name="J. Biol. Chem." volume="281" first="37893" last="37903">
<title>PGAM5, a Bcl-XL-interacting protein, is a novel substrate for the redox-regulated Keap1-dependent ubiquitin ligase complex.</title>
<authorList>
<person name="Lo S.-C."/>
<person name="Hannink M."/>
</authorList>
<dbReference type="PubMed" id="17046835"/>
<dbReference type="DOI" id="10.1074/jbc.m606539200"/>
</citation>
<scope>INTERACTION WITH PGAM5</scope>
<scope>FUNCTION</scope>
<scope>ACTIVITY REGULATION</scope>
<scope>DOMAIN</scope>
<scope>MUTAGENESIS OF CYS-151; TYR-334; ARG-415; ARG-483 AND TYR-572</scope>
</reference>
<reference key="17">
<citation type="journal article" date="2007" name="J. Biol. Chem." volume="282" first="2529" last="2537">
<title>Novel n-3 fatty acid oxidation products activate Nrf2 by destabilizing the association between Keap1 and Cullin3.</title>
<authorList>
<person name="Gao L."/>
<person name="Wang J."/>
<person name="Sekhar K.R."/>
<person name="Yin H."/>
<person name="Yared N.F."/>
<person name="Schneider S.N."/>
<person name="Sasi S."/>
<person name="Dalton T.P."/>
<person name="Anderson M.E."/>
<person name="Chan J.Y."/>
<person name="Morrow J.D."/>
<person name="Freeman M.L."/>
</authorList>
<dbReference type="PubMed" id="17127771"/>
<dbReference type="DOI" id="10.1074/jbc.m607622200"/>
</citation>
<scope>FUNCTION</scope>
<scope>ACTIVITY REGULATION</scope>
<scope>INTERACTION WITH CUL3</scope>
</reference>
<reference key="18">
<citation type="journal article" date="2008" name="Chem. Res. Toxicol." volume="21" first="705" last="710">
<title>Covalent modification at Cys151 dissociates the electrophile sensor Keap1 from the ubiquitin ligase CUL3.</title>
<authorList>
<person name="Rachakonda G."/>
<person name="Xiong Y."/>
<person name="Sekhar K.R."/>
<person name="Stamer S.L."/>
<person name="Liebler D.C."/>
<person name="Freeman M.L."/>
</authorList>
<dbReference type="PubMed" id="18251510"/>
<dbReference type="DOI" id="10.1021/tx700302s"/>
</citation>
<scope>FUNCTION</scope>
<scope>ACTIVITY REGULATION</scope>
<scope>DOMAIN</scope>
<scope>MUTAGENESIS OF CYS-151</scope>
</reference>
<reference key="19">
<citation type="journal article" date="2008" name="Exp. Cell Res." volume="314" first="1789" last="1803">
<title>PGAM5 tethers a ternary complex containing Keap1 and Nrf2 to mitochondria.</title>
<authorList>
<person name="Lo S.-C."/>
<person name="Hannink M."/>
</authorList>
<dbReference type="PubMed" id="18387606"/>
<dbReference type="DOI" id="10.1016/j.yexcr.2008.02.014"/>
</citation>
<scope>INTERACTION WITH NFE2L2 AND PGAM5</scope>
</reference>
<reference key="20">
<citation type="journal article" date="2009" name="PLoS ONE" volume="4" first="E5492" last="E5492">
<title>Ectodermal-neural cortex 1 down-regulates Nrf2 at the translational level.</title>
<authorList>
<person name="Wang X.J."/>
<person name="Zhang D.D."/>
</authorList>
<dbReference type="PubMed" id="19424503"/>
<dbReference type="DOI" id="10.1371/journal.pone.0005492"/>
</citation>
<scope>INTERACTION WITH ENC1</scope>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="21">
<citation type="journal article" date="2010" name="Autophagy" volume="6" first="614" last="621">
<title>Keap1 facilitates p62-mediated ubiquitin aggregate clearance via autophagy.</title>
<authorList>
<person name="Fan W."/>
<person name="Tang Z."/>
<person name="Chen D."/>
<person name="Moughon D."/>
<person name="Ding X."/>
<person name="Chen S."/>
<person name="Zhu M."/>
<person name="Zhong Q."/>
</authorList>
<dbReference type="PubMed" id="20495340"/>
<dbReference type="DOI" id="10.4161/auto.6.5.12189"/>
</citation>
<scope>INTERACTION WITH SQSTM1</scope>
<scope>ACTIVITY REGULATION</scope>
</reference>
<reference key="22">
<citation type="journal article" date="2010" name="J. Biol. Chem." volume="285" first="22576" last="22591">
<title>p62/SQSTM1 is a target gene for transcription factor NRF2 and creates a positive feedback loop by inducing antioxidant response element-driven gene transcription.</title>
<authorList>
<person name="Jain A."/>
<person name="Lamark T."/>
<person name="Sjoettem E."/>
<person name="Larsen K.B."/>
<person name="Awuh J.A."/>
<person name="Oevervatn A."/>
<person name="McMahon M."/>
<person name="Hayes J.D."/>
<person name="Johansen T."/>
</authorList>
<dbReference type="PubMed" id="20452972"/>
<dbReference type="DOI" id="10.1074/jbc.m110.118976"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH SQSTM1</scope>
<scope>ACTIVITY REGULATION</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>MUTAGENESIS OF ARG-380; ASN-382; ARG-415; HIS-436; ARG-483; TYR-525 AND TYR-572</scope>
</reference>
<reference key="23">
<citation type="journal article" date="2011" name="BMC Syst. Biol." volume="5" first="17" last="17">
<title>Initial characterization of the human central proteome.</title>
<authorList>
<person name="Burkard T.R."/>
<person name="Planyavsky M."/>
<person name="Kaupe I."/>
<person name="Breitwieser F.P."/>
<person name="Buerckstuemmer T."/>
<person name="Bennett K.L."/>
<person name="Superti-Furga G."/>
<person name="Colinge J."/>
</authorList>
<dbReference type="PubMed" id="21269460"/>
<dbReference type="DOI" id="10.1186/1752-0509-5-17"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="24">
<citation type="journal article" date="2013" name="Cell Metab." volume="17" first="73" last="84">
<title>Sestrins activate Nrf2 by promoting p62-dependent autophagic degradation of Keap1 and prevent oxidative liver damage.</title>
<authorList>
<person name="Bae S.H."/>
<person name="Sung S.H."/>
<person name="Oh S.Y."/>
<person name="Lim J.M."/>
<person name="Lee S.K."/>
<person name="Park Y.N."/>
<person name="Lee H.E."/>
<person name="Kang D."/>
<person name="Rhee S.G."/>
</authorList>
<dbReference type="PubMed" id="23274085"/>
<dbReference type="DOI" id="10.1016/j.cmet.2012.12.002"/>
</citation>
<scope>INTERACTION WITH SESN1 AND SESN2</scope>
</reference>
<reference key="25">
<citation type="journal article" date="2013" name="Nature" volume="502" first="254" last="257">
<title>Autophagy promotes primary ciliogenesis by removing OFD1 from centriolar satellites.</title>
<authorList>
<person name="Tang Z."/>
<person name="Lin M.G."/>
<person name="Stowe T.R."/>
<person name="Chen S."/>
<person name="Zhu M."/>
<person name="Stearns T."/>
<person name="Franco B."/>
<person name="Zhong Q."/>
</authorList>
<dbReference type="PubMed" id="24089205"/>
<dbReference type="DOI" id="10.1038/nature12606"/>
</citation>
<scope>INTERACTION WITH MAP1LC3B</scope>
</reference>
<reference key="26">
<citation type="journal article" date="2015" name="PLoS ONE" volume="10" first="E0141786" last="E0141786">
<title>Client proteins and small molecule inhibitors display distinct binding preferences for constitutive and stress-induced HSP90 isoforms and their conformationally restricted mutants.</title>
<authorList>
<person name="Prince T.L."/>
<person name="Kijima T."/>
<person name="Tatokoro M."/>
<person name="Lee S."/>
<person name="Tsutsumi S."/>
<person name="Yim K."/>
<person name="Rivas C."/>
<person name="Alarcon S."/>
<person name="Schwartz H."/>
<person name="Khamit-Kush K."/>
<person name="Scroggins B.T."/>
<person name="Beebe K."/>
<person name="Trepel J.B."/>
<person name="Neckers L."/>
</authorList>
<dbReference type="PubMed" id="26517842"/>
<dbReference type="DOI" id="10.1371/journal.pone.0141786"/>
</citation>
<scope>INTERACTION WITH HSP90AA1 AND HSP90AB1</scope>
</reference>
<reference key="27">
<citation type="journal article" date="2014" name="Cell Rep." volume="6" first="1017" last="1025">
<title>The Marburg virus VP24 protein interacts with Keap1 to activate the cytoprotective antioxidant response pathway.</title>
<authorList>
<person name="Edwards M.R."/>
<person name="Johnson B."/>
<person name="Mire C.E."/>
<person name="Xu W."/>
<person name="Shabman R.S."/>
<person name="Speller L.N."/>
<person name="Leung D.W."/>
<person name="Geisbert T.W."/>
<person name="Amarasinghe G.K."/>
<person name="Basler C.F."/>
</authorList>
<dbReference type="PubMed" id="24630991"/>
<dbReference type="DOI" id="10.1016/j.celrep.2014.01.043"/>
</citation>
<scope>INTERACTION WITH EBOLAVIRUS PROTEIN VP24 (MICROBIAL INFECTION)</scope>
</reference>
<reference key="28">
<citation type="journal article" date="2017" name="Cell Rep." volume="19" first="188" last="202">
<title>Keap1/cullin3 modulates p62/SQSTM1 activity via UBA domain ubiquitination.</title>
<authorList>
<person name="Lee Y."/>
<person name="Chou T.F."/>
<person name="Pittman S.K."/>
<person name="Keith A.L."/>
<person name="Razani B."/>
<person name="Weihl C.C."/>
</authorList>
<dbReference type="PubMed" id="28380357"/>
<dbReference type="DOI" id="10.1016/j.celrep.2017.03.030"/>
</citation>
<scope>FUNCTION</scope>
</reference>
<reference key="29">
<citation type="journal article" date="2018" name="Nature" volume="556" first="113" last="117">
<title>Itaconate is an anti-inflammatory metabolite that activates Nrf2 via alkylation of KEAP1.</title>
<authorList>
<person name="Mills E.L."/>
<person name="Ryan D.G."/>
<person name="Prag H.A."/>
<person name="Dikovskaya D."/>
<person name="Menon D."/>
<person name="Zaslona Z."/>
<person name="Jedrychowski M.P."/>
<person name="Costa A.S.H."/>
<person name="Higgins M."/>
<person name="Hams E."/>
<person name="Szpyt J."/>
<person name="Runtsch M.C."/>
<person name="King M.S."/>
<person name="McGouran J.F."/>
<person name="Fischer R."/>
<person name="Kessler B.M."/>
<person name="McGettrick A.F."/>
<person name="Hughes M.M."/>
<person name="Carroll R.G."/>
<person name="Booty L.M."/>
<person name="Knatko E.V."/>
<person name="Meakin P.J."/>
<person name="Ashford M.L.J."/>
<person name="Modis L.K."/>
<person name="Brunori G."/>
<person name="Sevin D.C."/>
<person name="Fallon P.G."/>
<person name="Caldwell S.T."/>
<person name="Kunji E.R.S."/>
<person name="Chouchani E.T."/>
<person name="Frezza C."/>
<person name="Dinkova-Kostova A.T."/>
<person name="Hartley R.C."/>
<person name="Murphy M.P."/>
<person name="O'Neill L.A."/>
</authorList>
<dbReference type="PubMed" id="29590092"/>
<dbReference type="DOI" id="10.1038/nature25986"/>
</citation>
<scope>FUNCTION</scope>
<scope>ALKYLATION AT CYS-151; CYS-257; CYS-273 AND CYS-288</scope>
<scope>ACTIVITY REGULATION</scope>
<scope>DOMAIN</scope>
<scope>MUTAGENESIS OF CYS-151</scope>
</reference>
<reference key="30">
<citation type="journal article" date="2018" name="Nature" volume="562" first="600" last="604">
<title>A metabolite-derived protein modification integrates glycolysis with KEAP1-NRF2 signalling.</title>
<authorList>
<person name="Bollong M.J."/>
<person name="Lee G."/>
<person name="Coukos J.S."/>
<person name="Yun H."/>
<person name="Zambaldo C."/>
<person name="Chang J.W."/>
<person name="Chin E.N."/>
<person name="Ahmad I."/>
<person name="Chatterjee A.K."/>
<person name="Lairson L.L."/>
<person name="Schultz P.G."/>
<person name="Moellering R.E."/>
</authorList>
<dbReference type="PubMed" id="30323285"/>
<dbReference type="DOI" id="10.1038/s41586-018-0622-0"/>
</citation>
<scope>CROSS-LINK AT ARG-135 AND CYS-151</scope>
<scope>ACTIVITY REGULATION</scope>
<scope>DOMAIN</scope>
<scope>MUTAGENESIS OF ARG-15; ARG-135 AND CYS-151</scope>
</reference>
<reference key="31">
<citation type="journal article" date="2017" name="J. Biol. Chem." volume="292" first="16817" last="16824">
<title>Stress-sensing mechanisms and the physiological roles of the Keap1-Nrf2 system during cellular stress.</title>
<authorList>
<person name="Suzuki T."/>
<person name="Yamamoto M."/>
</authorList>
<dbReference type="PubMed" id="28842501"/>
<dbReference type="DOI" id="10.1074/jbc.r117.800169"/>
</citation>
<scope>REVIEW</scope>
</reference>
<reference key="32">
<citation type="journal article" date="2004" name="Acta Crystallogr. D" volume="60" first="2346" last="2348">
<title>Crystallization and initial crystallographic analysis of the Kelch domain from human Keap1.</title>
<authorList>
<person name="Li X."/>
<person name="Zhang D."/>
<person name="Hannink M."/>
<person name="Beamer L.J."/>
</authorList>
<dbReference type="PubMed" id="15583386"/>
<dbReference type="DOI" id="10.1107/s0907444904024825"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (1.85 ANGSTROMS) OF 321-609</scope>
</reference>
<reference key="33">
<citation type="journal article" date="2005" name="Acta Crystallogr. D" volume="61" first="1335" last="1342">
<title>Conserved solvent and side-chain interactions in the 1.35 Angstrom structure of the Kelch domain of Keap1.</title>
<authorList>
<person name="Beamer L.J."/>
<person name="Li X."/>
<person name="Bottoms C.A."/>
<person name="Hannink M."/>
</authorList>
<dbReference type="PubMed" id="16204884"/>
<dbReference type="DOI" id="10.1107/s0907444905022626"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (1.35 ANGSTROMS) OF 321-609</scope>
</reference>
<reference key="34">
<citation type="journal article" date="2006" name="EMBO J." volume="25" first="3605" last="3617">
<title>Structure of the Keap1:Nrf2 interface provides mechanistic insight into Nrf2 signaling.</title>
<authorList>
<person name="Lo S.-C."/>
<person name="Li X."/>
<person name="Henzl M.T."/>
<person name="Beamer L.J."/>
<person name="Hannink M."/>
</authorList>
<dbReference type="PubMed" id="16888629"/>
<dbReference type="DOI" id="10.1038/sj.emboj.7601243"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (1.5 ANGSTROMS) OF 321-609 IN COMPLEX WITH NFE2L2</scope>
<scope>SUBUNIT</scope>
<scope>MUTAGENESIS OF TYR-334; ARG-380; ASN-382; ARG-415; HIS-436; PHE-478; ARG-483; TYR-525 AND TYR-572</scope>
</reference>
<reference key="35" evidence="3 4 5">
<citation type="journal article" date="2014" name="PLoS ONE" volume="9" first="e98896" last="e98896">
<title>Structure of the BTB domain of Keap1 and its interaction with the triterpenoid antagonist CDDO.</title>
<authorList>
<person name="Cleasby A."/>
<person name="Yon J."/>
<person name="Day P.J."/>
<person name="Richardson C."/>
<person name="Tickle I.J."/>
<person name="Williams P.A."/>
<person name="Callahan J.F."/>
<person name="Carr R."/>
<person name="Concha N."/>
<person name="Kerns J.K."/>
<person name="Qi H."/>
<person name="Sweitzer T."/>
<person name="Ward P."/>
<person name="Davies T.G."/>
</authorList>
<dbReference type="PubMed" id="24896564"/>
<dbReference type="DOI" id="10.1371/journal.pone.0098896"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.35 ANGSTROMS) OF 48-180</scope>
<scope>INTERACTION WITH CUL3</scope>
<scope>MUTAGENESIS OF CYS-151</scope>
</reference>
<reference key="36">
<citation type="journal article" date="2006" name="Mol. Cell" volume="21" first="689" last="700">
<title>Structural basis for defects of Keap1 activity provoked by its point mutations in lung cancer.</title>
<authorList>
<person name="Padmanabhan B."/>
<person name="Tong K.I."/>
<person name="Ohta T."/>
<person name="Nakamura Y."/>
<person name="Scharlock M."/>
<person name="Ohtsuji M."/>
<person name="Kang M."/>
<person name="Kobayashi A."/>
<person name="Yokoyama S."/>
<person name="Yamamoto M."/>
</authorList>
<dbReference type="PubMed" id="16507366"/>
<dbReference type="DOI" id="10.1016/j.molcel.2006.01.013"/>
</citation>
<scope>VARIANTS CYS-364 AND CYS-430</scope>
<scope>CHARACTERIZATION OF VARIANTS CYS-364 AND CYS-430</scope>
</reference>
<reference key="37">
<citation type="journal article" date="2006" name="PLoS Med." volume="3" first="1865" last="1876">
<title>Dysfunctional KEAP1-NRF2 interaction in non-small-cell lung cancer.</title>
<authorList>
<person name="Singh A."/>
<person name="Misra V."/>
<person name="Thimmulappa R.K."/>
<person name="Lee H."/>
<person name="Ames S."/>
<person name="Hoque M.O."/>
<person name="Herman J.G."/>
<person name="Baylin S.B."/>
<person name="Sidransky D."/>
<person name="Gabrielson E."/>
<person name="Brock M.V."/>
<person name="Biswal S."/>
</authorList>
<dbReference type="PubMed" id="17020408"/>
<dbReference type="DOI" id="10.1371/journal.pmed.0030420"/>
</citation>
<scope>VARIANTS PHE-167; HIS-236; LEU-284; CYS-333 AND SER-350</scope>
<scope>CHARACTERIZATION OF VARIANTS HIS-236 AND CYS-333</scope>
</reference>
<reference key="38">
<citation type="journal article" date="2006" name="Science" volume="314" first="268" last="274">
<title>The consensus coding sequences of human breast and colorectal cancers.</title>
<authorList>
<person name="Sjoeblom T."/>
<person name="Jones S."/>
<person name="Wood L.D."/>
<person name="Parsons D.W."/>
<person name="Lin J."/>
<person name="Barber T.D."/>
<person name="Mandelker D."/>
<person name="Leary R.J."/>
<person name="Ptak J."/>
<person name="Silliman N."/>
<person name="Szabo S."/>
<person name="Buckhaults P."/>
<person name="Farrell C."/>
<person name="Meeh P."/>
<person name="Markowitz S.D."/>
<person name="Willis J."/>
<person name="Dawson D."/>
<person name="Willson J.K.V."/>
<person name="Gazdar A.F."/>
<person name="Hartigan J."/>
<person name="Wu L."/>
<person name="Liu C."/>
<person name="Parmigiani G."/>
<person name="Park B.H."/>
<person name="Bachman K.E."/>
<person name="Papadopoulos N."/>
<person name="Vogelstein B."/>
<person name="Kinzler K.W."/>
<person name="Velculescu V.E."/>
</authorList>
<dbReference type="PubMed" id="16959974"/>
<dbReference type="DOI" id="10.1126/science.1133427"/>
</citation>
<scope>VARIANTS [LARGE SCALE ANALYSIS] TYR-23 AND VAL-522</scope>
</reference>
<comment type="function">
<text evidence="13 14 15 16 18 19 25 26 27 30 31 38 39">Substrate-specific adapter of a BCR (BTB-CUL3-RBX1) E3 ubiquitin ligase complex that regulates the response to oxidative stress by targeting NFE2L2/NRF2 for ubiquitination (PubMed:14585973, PubMed:15379550, PubMed:15572695, PubMed:15983046, PubMed:15601839). KEAP1 acts as a key sensor of oxidative and electrophilic stress: in normal conditions, the BCR(KEAP1) complex mediates ubiquitination and degradation of NFE2L2/NRF2, a transcription factor regulating expression of many cytoprotective genes (PubMed:15601839, PubMed:16006525). In response to oxidative stress, different electrophile metabolites trigger non-enzymatic covalent modifications of highly reactive cysteine residues in KEAP1, leading to inactivate the ubiquitin ligase activity of the BCR(KEAP1) complex, promoting NFE2L2/NRF2 nuclear accumulation and expression of phase II detoxifying enzymes (PubMed:19489739, PubMed:16006525, PubMed:17127771, PubMed:18251510, PubMed:29590092). In response to selective autophagy, KEAP1 is sequestered in inclusion bodies following its interaction with SQSTM1/p62, leading to inactivation of the BCR(KEAP1) complex and activation of NFE2L2/NRF2 (PubMed:20452972). The BCR(KEAP1) complex also mediates ubiquitination of SQSTM1/p62, increasing SQSTM1/p62 sequestering activity and degradation (PubMed:28380357). The BCR(KEAP1) complex also targets BPTF and PGAM5 for ubiquitination and degradation by the proteasome (PubMed:15379550, PubMed:17046835).</text>
</comment>
<comment type="activity regulation">
<text evidence="18 25 26 27 30 31 32 39 40">Ubiquitin ligase activity of the BCR(KEAP1) complex is inhibited by oxidative stress and electrophile metabolites such as sulforaphane (PubMed:15983046, PubMed:17046835, PubMed:29590092, PubMed:30323285). Electrophile metabolites react with reactive cysteine residues in KEAP1 and trigger non-enzymatic covalent modifications of these cysteine residues, leading to inactivate the ubiquitin ligase activity of the BCR(KEAP1) complex (PubMed:19489739, PubMed:17127771, PubMed:18251510, PubMed:29590092, PubMed:30323285). Selective autophagy also inactivates the BCR(KEAP1) complex via interaction between KEAP1 and SQSTM1/p62, which sequesters the complex in inclusion bodies and promotes its degradation (PubMed:20495340, PubMed:20452972).</text>
</comment>
<comment type="pathway" evidence="13 14 15 16 18">
<text>Protein modification; protein ubiquitination.</text>
</comment>
<comment type="subunit">
<text evidence="14 15 16 17 18 19 21 22 25 26 27 28 29 31 32 33 34 36 37">Component of the BCR(KEAP1) E3 ubiquitin ligase complex, at least composed of 2 molecules of CUL3, 2 molecules of KEAP1, and RBX1 (PubMed:15572695, PubMed:15983046, PubMed:15601839, PubMed:17127771, PubMed:18251510, PubMed:24896564). Interacts with NFE2L2/NRF2; the interaction is direct (PubMed:15379550, PubMed:15601839, PubMed:16006525, PubMed:18387606, PubMed:16888629). Forms a ternary complex with NFE2L2/NRF2 and PGAM5 (PubMed:17046835). Interacts with (phosphorylated) SQSTM1/p62; the interaction is direct and inactivates the BCR(KEAP1) complex by sequestering it in inclusion bodies, promoting its degradation (PubMed:20495340, PubMed:20452972). Interacts with NFE2L1 (PubMed:16687406). Interacts with BPTF and PTMA (PubMed:15657435). Interacts with MAP1LC3B (PubMed:24089205). Interacts indirectly with ENC1 (PubMed:19424503). Interacts with SESN1 and SESN2 (PubMed:23274085). Interacts with HSP90AA1 and HSP90AB1 (PubMed:26517842).</text>
</comment>
<comment type="subunit">
<text evidence="35">(Microbial infection) Interacts with ebolavirus protein VP24; this interaction activates transcription factor NFE2L2/NRF2 by blocking its interaction with KEAP1.</text>
</comment>
<comment type="interaction">
<interactant intactId="EBI-751001">
<id>Q14145</id>
</interactant>
<interactant intactId="EBI-6169747">
<id>Q5JTC6</id>
<label>AMER1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-751001">
<id>Q14145</id>
</interactant>
<interactant intactId="EBI-11954519">
<id>Q49AR9</id>
<label>ANKS1A</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-751001">
<id>Q14145</id>
</interactant>
<interactant intactId="EBI-750475">
<id>P45381</id>
<label>ASPA</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-751001">
<id>Q14145</id>
</interactant>
<interactant intactId="EBI-21977454">
<id>O14525-2</id>
<label>ASTN1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-751001">
<id>Q14145</id>
</interactant>
<interactant intactId="EBI-10175276">
<id>A9UGY9</id>
<label>ATG5</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-751001">
<id>Q14145</id>
</interactant>
<interactant intactId="EBI-1047414">
<id>Q9H1Y0</id>
<label>ATG5</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-751001">
<id>Q14145</id>
</interactant>
<interactant intactId="EBI-11603468">
<id>Q2NKX9</id>
<label>C2orf68</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-751001">
<id>Q14145</id>
</interactant>
<interactant intactId="EBI-3866279">
<id>Q9BWT7</id>
<label>CARD10</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-751001">
<id>Q14145</id>
</interactant>
<interactant intactId="EBI-745269">
<id>Q9NPC3</id>
<label>CCNB1IP1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-751001">
<id>Q14145</id>
</interactant>
<interactant intactId="EBI-982999">
<id>P02452</id>
<label>COL1A1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-751001">
<id>Q14145</id>
</interactant>
<interactant intactId="EBI-12375799">
<id>P02458-1</id>
<label>COL2A1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-751001">
<id>Q14145</id>
</interactant>
<interactant intactId="EBI-347804">
<id>P68400</id>
<label>CSNK2A1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-751001">
<id>Q14145</id>
</interactant>
<interactant intactId="EBI-456129">
<id>Q13618</id>
<label>CUL3</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>5</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-751001">
<id>Q14145</id>
</interactant>
<interactant intactId="EBI-718333">
<id>Q9NY33</id>
<label>DPP3</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>8</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-751001">
<id>Q14145</id>
</interactant>
<interactant intactId="EBI-769261">
<id>Q96JC9</id>
<label>EAF1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-751001">
<id>Q14145</id>
</interactant>
<interactant intactId="EBI-11343491">
<id>Q6P6B1</id>
<label>ERICH5</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-751001">
<id>Q14145</id>
</interactant>
<interactant intactId="EBI-750990">
<id>P62495</id>
<label>ETF1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>8</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-751001">
<id>Q14145</id>
</interactant>
<interactant intactId="EBI-3893327">
<id>Q6P1L5</id>
<label>FAM117B</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>6</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-751001">
<id>Q14145</id>
</interactant>
<interactant intactId="EBI-10232920">
<id>Q14440</id>
<label>GPErik</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-751001">
<id>Q14145</id>
</interactant>
<interactant intactId="EBI-11955647">
<id>Q8TDV0</id>
<label>GPR151</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-751001">
<id>Q14145</id>
</interactant>
<interactant intactId="EBI-12044847">
<id>A0A0C4DFT7</id>
<label>GYPA</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-751001">
<id>Q14145</id>
</interactant>
<interactant intactId="EBI-10176190">
<id>B8Q183</id>
<label>GYPA</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-751001">
<id>Q14145</id>
</interactant>
<interactant intactId="EBI-702665">
<id>P02724</id>
<label>GYPA</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-751001">
<id>Q14145</id>
</interactant>
<interactant intactId="EBI-1035358">
<id>P05362</id>
<label>ICAM1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-751001">
<id>Q14145</id>
</interactant>
<interactant intactId="EBI-6115771">
<id>Q9BYX4</id>
<label>IFIH1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-751001">
<id>Q14145</id>
</interactant>
<interactant intactId="EBI-81266">
<id>O14920</id>
<label>IKBKB</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>6</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-751001">
<id>Q14145</id>
</interactant>
<interactant intactId="EBI-12206419">
<id>Q4KMZ1</id>
<label>IQCC</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-751001">
<id>Q14145</id>
</interactant>
<interactant intactId="EBI-746999">
<id>O95198</id>
<label>KLHL2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-751001">
<id>Q14145</id>
</interactant>
<interactant intactId="EBI-10230467">
<id>Q8N4I8</id>
<label>KLHL3</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-751001">
<id>Q14145</id>
</interactant>
<interactant intactId="EBI-8524663">
<id>Q9UH77</id>
<label>KLHL3</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-751001">
<id>Q14145</id>
</interactant>
<interactant intactId="EBI-348239">
<id>P62310</id>
<label>LSM3</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>6</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-751001">
<id>Q14145</id>
</interactant>
<interactant intactId="EBI-78203">
<id>Q13257</id>
<label>MAD2L1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>8</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-751001">
<id>Q14145</id>
</interactant>
<interactant intactId="EBI-947402">
<id>O60336</id>
<label>MAPKBP1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-751001">
<id>Q14145</id>
</interactant>
<interactant intactId="EBI-9384556">
<id>Q9BTE3-2</id>
<label>MCMBP</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-751001">
<id>Q14145</id>
</interactant>
<interactant intactId="EBI-2007911">
<id>Q16236</id>
<label>NFE2L2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>31</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-751001">
<id>Q14145</id>
</interactant>
<interactant intactId="EBI-2514593">
<id>Q96TA1</id>
<label>NIBAN2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>9</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-751001">
<id>Q14145</id>
</interactant>
<interactant intactId="EBI-741158">
<id>Q96HA8</id>
<label>NTAQ1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-751001">
<id>Q14145</id>
</interactant>
<interactant intactId="EBI-4280066">
<id>Q9NZJ9</id>
<label>NUDT4</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-751001">
<id>Q14145</id>
</interactant>
<interactant intactId="EBI-2371082">
<id>Q9UKX7</id>
<label>NUP50</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-751001">
<id>Q14145</id>
</interactant>
<interactant intactId="EBI-10265887">
<id>Q8N573-5</id>
<label>OXR1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-751001">
<id>Q14145</id>
</interactant>
<interactant intactId="EBI-1222653">
<id>Q86YC2</id>
<label>PALB2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-751001">
<id>Q14145</id>
</interactant>
<interactant intactId="EBI-1181439">
<id>P54619</id>
<label>PRKAG1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>6</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-751001">
<id>Q14145</id>
</interactant>
<interactant intactId="EBI-10194874">
<id>P06454-2</id>
<label>PTMA</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>6</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-751001">
<id>Q14145</id>
</interactant>
<interactant intactId="EBI-10253121">
<id>Q6P9E2</id>
<label>RECK</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>6</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-751001">
<id>Q14145</id>
</interactant>
<interactant intactId="EBI-73886">
<id>Q04206</id>
<label>RELA</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-751001">
<id>Q14145</id>
</interactant>
<interactant intactId="EBI-3939642">
<id>P58004</id>
<label>SESN2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-751001">
<id>Q14145</id>
</interactant>
<interactant intactId="EBI-358489">
<id>Q96GM5</id>
<label>SMARCD1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-751001">
<id>Q14145</id>
</interactant>
<interactant intactId="EBI-307104">
<id>Q13501</id>
<label>SQSTM1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>18</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-751001">
<id>Q14145</id>
</interactant>
<interactant intactId="EBI-1553984">
<id>Q9UGK3</id>
<label>STAP2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-751001">
<id>Q14145</id>
</interactant>
<interactant intactId="EBI-3258000">
<id>Q9P0N9</id>
<label>TBC1D7</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-751001">
<id>Q14145</id>
</interactant>
<interactant intactId="EBI-710997">
<id>P54274</id>
<label>TERF1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-751001">
<id>Q14145</id>
</interactant>
<interactant intactId="EBI-739485">
<id>Q9Y3Q8</id>
<label>TSC22D4</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-751001">
<id>Q14145</id>
</interactant>
<interactant intactId="EBI-7705033">
<id>Q9BRX9</id>
<label>WDR83</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>7</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-751001">
<id>Q14145</id>
</interactant>
<interactant intactId="EBI-310886">
<id>Q9P202</id>
<label>WHRN</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-751001">
<id>Q14145</id>
</interactant>
<interactant intactId="EBI-1228269">
<id>P58317</id>
<label>ZNF121</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-751001">
<id>Q14145</id>
</interactant>
<interactant intactId="EBI-739949">
<id>Q9NX65</id>
<label>ZSCAN32</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-751001">
<id>Q14145</id>
</interactant>
<interactant intactId="EBI-447960">
<id>O88351</id>
<label>Ikbkb</label>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-751001">
<id>Q14145</id>
</interactant>
<interactant intactId="EBI-6115486">
<id>P15314</id>
<label>Irf1</label>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-751001">
<id>Q14145</id>
</interactant>
<interactant intactId="EBI-645025">
<id>Q64337</id>
<label>Sqstm1</label>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="subcellular location">
<subcellularLocation>
<location evidence="13 14 16 17 29">Cytoplasm</location>
</subcellularLocation>
<subcellularLocation>
<location evidence="17">Nucleus</location>
</subcellularLocation>
<text evidence="16 31">Mainly cytoplasmic (PubMed:15601839). In response to selective autophagy, relocalizes to inclusion bodies following interaction with SQSTM1/p62 (PubMed:20452972).</text>
</comment>
<comment type="tissue specificity">
<text evidence="14">Broadly expressed, with highest levels in skeletal muscle.</text>
</comment>
<comment type="domain">
<text evidence="26 27 30 39 40">KEAP1 contains reactive cysteine residues that act as sensors for endogenously produced and exogenously encountered small molecules, which react with sulfhydryl groups and modify the cysteine sensors, leading to impair ability of the BCR(KEAP1) complex to ubiquitinate target proteins.</text>
</comment>
<comment type="domain">
<text evidence="25">The Kelch repeats mediate interaction with NFE2L2/NRF2, BPTF and PGAM5.</text>
</comment>
<comment type="PTM">
<text evidence="11 26 27 39 40">Non-enzymatic covalent modifications of reactive cysteines by electrophile metabolites inactivate the BCR(KEAP1) complex (PubMed:17127771, PubMed:18251510, PubMed:29590092, PubMed:30323285). Accumulation of fumarate promotes the formation of cysteine S-succination (S-(2-succinyl)cysteine), leading to inactivate the BCR(KEAP1) complex and promote NFE2L2/NRF2 nuclear accumulation and activation (By similarity). Nitric oxide-dependent 8-Nitro-cGMP formation promotes cysteine guanylation (S-cGMP-cysteine), leading to NFE2L2/NRF2 nuclear accumulation and activation (By similarity). Itaconate, an anti-inflammatory metabolite generated in response to lipopolysaccharide, alkylates cysteines, activating NFE2L2/NRF2 (PubMed:29590092). Methylglyoxal, a reactive metabolite that accumulates when the glycolytic enzyme PGK1 is inhibited, promotes formation of a methylimidazole cross-link between proximal Cys-151 and Arg-135 on another KEAP1 molecule, resulting in an inactive dimer that inactivates the BCR(KEAP1) complex (PubMed:30323285).</text>
</comment>
<comment type="PTM">
<text evidence="18 31">Degraded via a proteasomal-independent process during selective autophagy: interaction with phosphorylated SQSTM1/p62 sequesters KEAP1 in inclusion bodies, leading to its degradation.</text>
</comment>
<comment type="PTM">
<text evidence="15 18">Auto-ubiquitinated by the BCR(KEAP1) complex (PubMed:15572695, PubMed:15983046). Quinone-induced oxidative stress, but not sulforaphane, increases its ubiquitination (PubMed:15572695, PubMed:15983046). Ubiquitination and subsequent degradation is most pronounced following prolonged exposure of cells to oxidative stress, particularly in glutathione-deficient cells that are highly susceptible to oxidative stress (PubMed:15572695, PubMed:15983046).</text>
</comment>
<comment type="similarity">
<text evidence="45">Belongs to the KEAP1 family.</text>
</comment>
<comment type="caution">
<text evidence="11 19 26 27 36">The mechanism of inactivation of the BCR(KEAP1) complex by covalent modifications of reactive cysteines is unclear. Covalent modifications were initially thought to disrupt interaction between KEAP1 and NFE2L2/NRF2 (By similarity). Recent publications suggest that cysteine modifications disrupt the interaction between KEAP1 and CUL3 without affecting the interaction between KEAP1 and NFE2L2/NRF2 (PubMed:16006525, PubMed:17127771, PubMed:18251510, PubMed:24896564).</text>
</comment>
<comment type="sequence caution" evidence="45">
<conflict type="erroneous initiation">
<sequence resource="EMBL-CDS" id="BAA09481" version="3"/>
</conflict>
<text>Extended N-terminus.</text>
</comment>
<dbReference type="EMBL" id="AF361892">
<property type="protein sequence ID" value="AAK43722.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AF361888">
<property type="protein sequence ID" value="AAK43722.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AF361889">
<property type="protein sequence ID" value="AAK43722.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AF361890">
<property type="protein sequence ID" value="AAK43722.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AF361891">
<property type="protein sequence ID" value="AAK43722.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AF361886">
<property type="protein sequence ID" value="AAK51082.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="D50922">
<property type="protein sequence ID" value="BAA09481.3"/>
<property type="status" value="ALT_INIT"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AK056204">
<property type="protein sequence ID" value="BAG51647.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AC011461">
<property type="status" value="NOT_ANNOTATED_CDS"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="BC002417">
<property type="protein sequence ID" value="AAH02417.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BC002930">
<property type="protein sequence ID" value="AAH02930.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BC015945">
<property type="protein sequence ID" value="AAH15945.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BC021957">
<property type="protein sequence ID" value="AAH21957.2"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="CCDS" id="CCDS12239.1"/>
<dbReference type="RefSeq" id="NP_036421.2">
<property type="nucleotide sequence ID" value="NM_012289.3"/>
</dbReference>
<dbReference type="RefSeq" id="NP_987096.1">
<property type="nucleotide sequence ID" value="NM_203500.1"/>
</dbReference>
<dbReference type="RefSeq" id="XP_005260230.1">
<property type="nucleotide sequence ID" value="XM_005260173.1"/>
</dbReference>
<dbReference type="RefSeq" id="XP_005260231.1">
<property type="nucleotide sequence ID" value="XM_005260174.1"/>
</dbReference>
<dbReference type="RefSeq" id="XP_011526754.1">
<property type="nucleotide sequence ID" value="XM_011528452.1"/>
</dbReference>
<dbReference type="PDB" id="1U6D">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.85"/>
<property type="chains" value="X=321-609"/>
</dbReference>
<dbReference type="PDB" id="1ZGK">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.35"/>
<property type="chains" value="A=321-609"/>
</dbReference>
<dbReference type="PDB" id="2FLU">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.50"/>
<property type="chains" value="X=321-609"/>
</dbReference>
<dbReference type="PDB" id="3VNG">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.10"/>
<property type="chains" value="A=321-609"/>
</dbReference>
<dbReference type="PDB" id="3VNH">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.10"/>
<property type="chains" value="A=321-609"/>
</dbReference>
<dbReference type="PDB" id="3ZGC">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.20"/>
<property type="chains" value="A/B=321-609"/>
</dbReference>
<dbReference type="PDB" id="3ZGD">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.98"/>
<property type="chains" value="A/B=321-609"/>
</dbReference>
<dbReference type="PDB" id="4CXI">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.35"/>
<property type="chains" value="A=48-180"/>
</dbReference>
<dbReference type="PDB" id="4CXJ">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.80"/>
<property type="chains" value="A=48-180"/>
</dbReference>
<dbReference type="PDB" id="4CXT">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.66"/>
<property type="chains" value="A=48-180"/>
</dbReference>
<dbReference type="PDB" id="4IFJ">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.80"/>
<property type="chains" value="A=321-609"/>
</dbReference>
<dbReference type="PDB" id="4IFL">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.80"/>
<property type="chains" value="X=321-609"/>
</dbReference>
<dbReference type="PDB" id="4IFN">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.40"/>
<property type="chains" value="X=321-609"/>
</dbReference>
<dbReference type="PDB" id="4IN4">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.59"/>
<property type="chains" value="A/B/C=321-609"/>
</dbReference>
<dbReference type="PDB" id="4IQK">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.97"/>
<property type="chains" value="A=321-609"/>
</dbReference>
<dbReference type="PDB" id="4L7B">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.41"/>
<property type="chains" value="A/B=321-609"/>
</dbReference>
<dbReference type="PDB" id="4L7C">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.40"/>
<property type="chains" value="A/B/C=321-609"/>
</dbReference>
<dbReference type="PDB" id="4L7D">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.25"/>
<property type="chains" value="A/B/C=321-609"/>
</dbReference>
<dbReference type="PDB" id="4N1B">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.55"/>
<property type="chains" value="A/B/C=321-609"/>
</dbReference>
<dbReference type="PDB" id="4XMB">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.43"/>
<property type="chains" value="A=321-609"/>
</dbReference>
<dbReference type="PDB" id="5DAD">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.61"/>
<property type="chains" value="A=49-182"/>
</dbReference>
<dbReference type="PDB" id="5DAF">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.37"/>
<property type="chains" value="A=49-182"/>
</dbReference>
<dbReference type="PDB" id="5F72">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.85"/>
<property type="chains" value="C/K=321-611"/>
</dbReference>
<dbReference type="PDB" id="5GIT">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.19"/>
<property type="chains" value="A=48-180"/>
</dbReference>
<dbReference type="PDB" id="5NLB">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.45"/>
<property type="chains" value="A=51-204"/>
</dbReference>
<dbReference type="PDB" id="5WFL">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.93"/>
<property type="chains" value="A/B=312-624"/>
</dbReference>
<dbReference type="PDB" id="5WFV">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.91"/>
<property type="chains" value="A/B=320-612"/>
</dbReference>
<dbReference type="PDB" id="5WG1">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.02"/>
<property type="chains" value="A/B=320-612"/>
</dbReference>
<dbReference type="PDB" id="5WHL">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.50"/>
<property type="chains" value="A/B=312-624"/>
</dbReference>
<dbReference type="PDB" id="5WHO">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.23"/>
<property type="chains" value="A/B=312-624"/>
</dbReference>
<dbReference type="PDB" id="5WIY">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.23"/>
<property type="chains" value="A/B=312-624"/>
</dbReference>
<dbReference type="PDB" id="5X54">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.30"/>
<property type="chains" value="A/B=321-609"/>
</dbReference>
<dbReference type="PDB" id="6FFM">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.20"/>
<property type="chains" value="A=48-180"/>
</dbReference>
<dbReference type="PDB" id="6FMP">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.92"/>
<property type="chains" value="A/B=321-609"/>
</dbReference>
<dbReference type="PDB" id="6FMQ">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.10"/>
<property type="chains" value="A/B=321-609"/>
</dbReference>
<dbReference type="PDB" id="6HWS">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.75"/>
<property type="chains" value="A=321-609"/>
</dbReference>
<dbReference type="PDB" id="6ROG">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.16"/>
<property type="chains" value="A/X=321-609"/>
</dbReference>
<dbReference type="PDB" id="6SP1">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.57"/>
<property type="chains" value="A/B=321-609"/>
</dbReference>
<dbReference type="PDB" id="6SP4">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.59"/>
<property type="chains" value="A/B/C/D/E/F=321-609"/>
</dbReference>
<dbReference type="PDB" id="6TYM">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.42"/>
<property type="chains" value="A=321-609"/>
</dbReference>
<dbReference type="PDB" id="6TYP">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.50"/>
<property type="chains" value="A=321-609"/>
</dbReference>
<dbReference type="PDB" id="6UF0">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.96"/>
<property type="chains" value="A/B=321-609"/>
</dbReference>
<dbReference type="PDB" id="6V6Z">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.60"/>
<property type="chains" value="A/B/C/D=321-609"/>
</dbReference>
<dbReference type="PDBsum" id="1U6D"/>
<dbReference type="PDBsum" id="1ZGK"/>
<dbReference type="PDBsum" id="2FLU"/>
<dbReference type="PDBsum" id="3VNG"/>
<dbReference type="PDBsum" id="3VNH"/>
<dbReference type="PDBsum" id="3ZGC"/>
<dbReference type="PDBsum" id="3ZGD"/>
<dbReference type="PDBsum" id="4CXI"/>
<dbReference type="PDBsum" id="4CXJ"/>
<dbReference type="PDBsum" id="4CXT"/>
<dbReference type="PDBsum" id="4IFJ"/>
<dbReference type="PDBsum" id="4IFL"/>
<dbReference type="PDBsum" id="4IFN"/>
<dbReference type="PDBsum" id="4IN4"/>
<dbReference type="PDBsum" id="4IQK"/>
<dbReference type="PDBsum" id="4L7B"/>
<dbReference type="PDBsum" id="4L7C"/>
<dbReference type="PDBsum" id="4L7D"/>
<dbReference type="PDBsum" id="4N1B"/>
<dbReference type="PDBsum" id="4XMB"/>
<dbReference type="PDBsum" id="5DAD"/>
<dbReference type="PDBsum" id="5DAF"/>
<dbReference type="PDBsum" id="5F72"/>
<dbReference type="PDBsum" id="5GIT"/>
<dbReference type="PDBsum" id="5NLB"/>
<dbReference type="PDBsum" id="5WFL"/>
<dbReference type="PDBsum" id="5WFV"/>
<dbReference type="PDBsum" id="5WG1"/>
<dbReference type="PDBsum" id="5WHL"/>
<dbReference type="PDBsum" id="5WHO"/>
<dbReference type="PDBsum" id="5WIY"/>
<dbReference type="PDBsum" id="5X54"/>
<dbReference type="PDBsum" id="6FFM"/>
<dbReference type="PDBsum" id="6FMP"/>
<dbReference type="PDBsum" id="6FMQ"/>
<dbReference type="PDBsum" id="6HWS"/>
<dbReference type="PDBsum" id="6ROG"/>
<dbReference type="PDBsum" id="6SP1"/>
<dbReference type="PDBsum" id="6SP4"/>
<dbReference type="PDBsum" id="6TYM"/>
<dbReference type="PDBsum" id="6TYP"/>
<dbReference type="PDBsum" id="6UF0"/>
<dbReference type="PDBsum" id="6V6Z"/>
<dbReference type="BMRB" id="Q14145"/>
<dbReference type="SMR" id="Q14145"/>
<dbReference type="BioGRID" id="115156">
<property type="interactions" value="186"/>
</dbReference>
<dbReference type="CORUM" id="Q14145"/>
<dbReference type="DIP" id="DIP-42134N"/>
<dbReference type="ELM" id="Q14145"/>
<dbReference type="IntAct" id="Q14145">
<property type="interactions" value="141"/>
</dbReference>
<dbReference type="MINT" id="Q14145"/>
<dbReference type="STRING" id="9606.ENSP00000171111"/>
<dbReference type="BindingDB" id="Q14145"/>
<dbReference type="ChEMBL" id="CHEMBL2069156"/>
<dbReference type="DrugBank" id="DB08908">
<property type="generic name" value="Dimethyl fumarate"/>
</dbReference>
<dbReference type="DrugCentral" id="Q14145"/>
<dbReference type="GuidetoPHARMACOLOGY" id="2757"/>
<dbReference type="iPTMnet" id="Q14145"/>
<dbReference type="PhosphoSitePlus" id="Q14145"/>
<dbReference type="SwissPalm" id="Q14145"/>
<dbReference type="BioMuta" id="KEAP1"/>
<dbReference type="DMDM" id="146345444"/>
<dbReference type="EPD" id="Q14145"/>
<dbReference type="jPOST" id="Q14145"/>
<dbReference type="MassIVE" id="Q14145"/>
<dbReference type="MaxQB" id="Q14145"/>
<dbReference type="PaxDb" id="Q14145"/>
<dbReference type="PeptideAtlas" id="Q14145"/>
<dbReference type="PRIDE" id="Q14145"/>
<dbReference type="ProteomicsDB" id="59849"/>
<dbReference type="ABCD" id="Q14145">
<property type="antibodies" value="5 sequenced antibodies"/>
</dbReference>
<dbReference type="Antibodypedia" id="1418">
<property type="antibodies" value="670 antibodies"/>
</dbReference>
<dbReference type="DNASU" id="9817"/>
<dbReference type="Ensembl" id="ENST00000171111">
<property type="protein sequence ID" value="ENSP00000171111"/>
<property type="gene ID" value="ENSG00000079999"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000393623">
<property type="protein sequence ID" value="ENSP00000377245"/>
<property type="gene ID" value="ENSG00000079999"/>
</dbReference>
<dbReference type="GeneID" id="9817"/>
<dbReference type="KEGG" id="hsa:9817"/>
<dbReference type="UCSC" id="uc002moq.2">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="CTD" id="9817"/>
<dbReference type="DisGeNET" id="9817"/>
<dbReference type="EuPathDB" id="HostDB:ENSG00000079999.13"/>
<dbReference type="GeneCards" id="KEAP1"/>
<dbReference type="HGNC" id="HGNC:23177">
<property type="gene designation" value="KEAP1"/>
</dbReference>
<dbReference type="HPA" id="ENSG00000079999">
<property type="expression patterns" value="Low tissue specificity"/>
</dbReference>
<dbReference type="MalaCards" id="KEAP1"/>
<dbReference type="MIM" id="606016">
<property type="type" value="gene"/>
</dbReference>
<dbReference type="neXtProt" id="NX_Q14145"/>
<dbReference type="OpenTargets" id="ENSG00000079999"/>
<dbReference type="Orphanet" id="276399">
<property type="disease" value="Familial multinodular goiter"/>
</dbReference>
<dbReference type="PharmGKB" id="PA134887774"/>
<dbReference type="eggNOG" id="KOG4441">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="GeneTree" id="ENSGT00940000159543"/>
<dbReference type="HOGENOM" id="CLU_004253_14_2_1"/>
<dbReference type="InParanoid" id="Q14145"/>
<dbReference type="KO" id="K10456"/>
<dbReference type="OMA" id="CYHPEND"/>
<dbReference type="OrthoDB" id="746011at2759"/>
<dbReference type="PhylomeDB" id="Q14145"/>
<dbReference type="TreeFam" id="TF329218"/>
<dbReference type="PathwayCommons" id="Q14145"/>
<dbReference type="Reactome" id="R-HSA-5689880">
<property type="pathway name" value="Ub-specific processing proteases"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-8951664">
<property type="pathway name" value="Neddylation"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-983168">
<property type="pathway name" value="Antigen processing: Ubiquitination &amp; Proteasome degradation"/>
</dbReference>
<dbReference type="SIGNOR" id="Q14145"/>
<dbReference type="UniPathway" id="UPA00143"/>
<dbReference type="BioGRID-ORCS" id="9817">
<property type="hits" value="136 hits in 892 CRISPR screens"/>
</dbReference>
<dbReference type="ChiTaRS" id="KEAP1">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="EvolutionaryTrace" id="Q14145"/>
<dbReference type="GeneWiki" id="KEAP1"/>
<dbReference type="GenomeRNAi" id="9817"/>
<dbReference type="Pharos" id="Q14145">
<property type="development level" value="Tclin"/>
</dbReference>
<dbReference type="PRO" id="PR:Q14145"/>
<dbReference type="Proteomes" id="UP000005640">
<property type="component" value="Chromosome 19"/>
</dbReference>
<dbReference type="RNAct" id="Q14145">
<property type="molecule type" value="protein"/>
</dbReference>
<dbReference type="Bgee" id="ENSG00000079999">
<property type="expression patterns" value="Expressed in hindlimb stylopod muscle and 244 other tissues"/>
</dbReference>
<dbReference type="ExpressionAtlas" id="Q14145">
<property type="expression patterns" value="baseline and differential"/>
</dbReference>
<dbReference type="Genevisible" id="Q14145">
<property type="organism ID" value="HS"/>
</dbReference>
<dbReference type="GO" id="GO:0005884">
<property type="term" value="C:actin filament"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0034451">
<property type="term" value="C:centriolar satellite"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="HPA"/>
</dbReference>
<dbReference type="GO" id="GO:0031463">
<property type="term" value="C:Cul3-RING ubiquitin ligase complex"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005737">
<property type="term" value="C:cytoplasm"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005829">
<property type="term" value="C:cytosol"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="HPA"/>
</dbReference>
<dbReference type="GO" id="GO:0005783">
<property type="term" value="C:endoplasmic reticulum"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0016234">
<property type="term" value="C:inclusion body"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0030496">
<property type="term" value="C:midbody"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005654">
<property type="term" value="C:nucleoplasm"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="HPA"/>
</dbReference>
<dbReference type="GO" id="GO:0097718">
<property type="term" value="F:disordered domain specific binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0042802">
<property type="term" value="F:identical protein binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0008134">
<property type="term" value="F:transcription factor binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="ParkinsonsUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0071353">
<property type="term" value="P:cellular response to interleukin-4"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0034599">
<property type="term" value="P:cellular response to oxidative stress"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0042994">
<property type="term" value="P:cytoplasmic sequestering of transcription factor"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0001701">
<property type="term" value="P:in utero embryonic development"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0043433">
<property type="term" value="P:negative regulation of DNA-binding transcription factor activity"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ParkinsonsUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0032436">
<property type="term" value="P:positive regulation of proteasomal ubiquitin-dependent protein catabolic process"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ParkinsonsUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0043687">
<property type="term" value="P:post-translational protein modification"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0016579">
<property type="term" value="P:protein deubiquitination"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0016567">
<property type="term" value="P:protein ubiquitination"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0010506">
<property type="term" value="P:regulation of autophagy"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0045604">
<property type="term" value="P:regulation of epidermal cell differentiation"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0006511">
<property type="term" value="P:ubiquitin-dependent protein catabolic process"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0016032">
<property type="term" value="P:viral process"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="Gene3D" id="2.120.10.80">
<property type="match status" value="1"/>
</dbReference>
<dbReference type="IDEAL" id="IID00384"/>
<dbReference type="InterPro" id="IPR011705">
<property type="entry name" value="BACK"/>
</dbReference>
<dbReference type="InterPro" id="IPR017096">
<property type="entry name" value="BTB-kelch_protein"/>
</dbReference>
<dbReference type="InterPro" id="IPR000210">
<property type="entry name" value="BTB/POZ_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR030563">
<property type="entry name" value="KEAP1"/>
</dbReference>
<dbReference type="InterPro" id="IPR015915">
<property type="entry name" value="Kelch-typ_b-propeller"/>
</dbReference>
<dbReference type="InterPro" id="IPR006652">
<property type="entry name" value="Kelch_1"/>
</dbReference>
<dbReference type="InterPro" id="IPR011333">
<property type="entry name" value="SKP1/BTB/POZ_sf"/>
</dbReference>
<dbReference type="PANTHER" id="PTHR24412:SF162">
<property type="entry name" value="PTHR24412:SF162"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF07707">
<property type="entry name" value="BACK"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF00651">
<property type="entry name" value="BTB"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF01344">
<property type="entry name" value="Kelch_1"/>
<property type="match status" value="6"/>
</dbReference>
<dbReference type="PIRSF" id="PIRSF037037">
<property type="entry name" value="Kelch-like_protein_gigaxonin"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SMART" id="SM00875">
<property type="entry name" value="BACK"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SMART" id="SM00225">
<property type="entry name" value="BTB"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SMART" id="SM00612">
<property type="entry name" value="Kelch"/>
<property type="match status" value="6"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF117281">
<property type="entry name" value="SSF117281"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF54695">
<property type="entry name" value="SSF54695"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS50097">
<property type="entry name" value="BTB"/>
<property type="match status" value="1"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0002">3D-structure</keyword>
<keyword id="KW-0963">Cytoplasm</keyword>
<keyword id="KW-0945">Host-virus interaction</keyword>
<keyword id="KW-0880">Kelch repeat</keyword>
<keyword id="KW-0539">Nucleus</keyword>
<keyword id="KW-0621">Polymorphism</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0677">Repeat</keyword>
<keyword id="KW-0702">S-nitrosylation</keyword>
<keyword id="KW-0832">Ubl conjugation</keyword>
<keyword id="KW-0833">Ubl conjugation pathway</keyword>
<feature type="chain" description="Kelch-like ECH-associated protein 1" id="PRO_0000119093">
<location>
<begin position="1"/>
<end position="624"/>
</location>
</feature>
<feature type="domain" description="BTB" evidence="12">
<location>
<begin position="77"/>
<end position="149"/>
</location>
</feature>
<feature type="domain" description="BACK">
<location>
<begin position="184"/>
<end position="286"/>
</location>
</feature>
<feature type="repeat" description="Kelch 1">
<location>
<begin position="327"/>
<end position="372"/>
</location>
</feature>
<feature type="repeat" description="Kelch 2">
<location>
<begin position="373"/>
<end position="423"/>
</location>
</feature>
<feature type="repeat" description="Kelch 3">
<location>
<begin position="424"/>
<end position="470"/>
</location>
</feature>
<feature type="repeat" description="Kelch 4">
<location>
<begin position="471"/>
<end position="517"/>
</location>
</feature>
<feature type="repeat" description="Kelch 5">
<location>
<begin position="518"/>
<end position="564"/>
</location>
</feature>
<feature type="repeat" description="Kelch 6">
<location>
<begin position="565"/>
<end position="611"/>
</location>
</feature>
<feature type="site" description="Sensor for electrophilic agents" evidence="27 39">
<location>
<position position="151"/>
</location>
</feature>
<feature type="site" description="Sensor for electrophilic agents" evidence="39">
<location>
<position position="257"/>
</location>
</feature>
<feature type="site" description="Sensor for electrophilic agents" evidence="39">
<location>
<position position="273"/>
</location>
</feature>
<feature type="site" description="Sensor for electrophilic agents" evidence="39">
<location>
<position position="288"/>
</location>
</feature>
<feature type="site" description="Sensor for electrophilic agents" evidence="11">
<location>
<position position="434"/>
</location>
</feature>
<feature type="modified residue" description="S-(2-succinyl)cysteine" evidence="11">
<location>
<position position="38"/>
</location>
</feature>
<feature type="modified residue" description="S-(2,3-dicarboxypropyl)cysteine; alternate" evidence="39">
<location>
<position position="151"/>
</location>
</feature>
<feature type="modified residue" description="S-(2-succinyl)cysteine; alternate" evidence="11">
<location>
<position position="151"/>
</location>
</feature>
<feature type="modified residue" description="S-nitrosocysteine; alternate" evidence="11">
<location>
<position position="151"/>
</location>
</feature>
<feature type="modified residue" description="S-(2-succinyl)cysteine" evidence="11">
<location>
<position position="241"/>
</location>
</feature>
<feature type="modified residue" description="S-(2,3-dicarboxypropyl)cysteine" evidence="39">
<location>
<position position="257"/>
</location>
</feature>
<feature type="modified residue" description="S-(2,3-dicarboxypropyl)cysteine" evidence="39">
<location>
<position position="273"/>
</location>
</feature>
<feature type="modified residue" description="S-(2,3-dicarboxypropyl)cysteine; alternate" evidence="39">
<location>
<position position="288"/>
</location>
</feature>
<feature type="modified residue" description="S-(2-succinyl)cysteine; alternate" evidence="11">
<location>
<position position="288"/>
</location>
</feature>
<feature type="modified residue" description="S-(2-succinyl)cysteine" evidence="11">
<location>
<position position="319"/>
</location>
</feature>
<feature type="modified residue" description="S-cGMP-cysteine" evidence="11">
<location>
<position position="434"/>
</location>
</feature>
<feature type="modified residue" description="S-(2-succinyl)cysteine" evidence="11">
<location>
<position position="613"/>
</location>
</feature>
<feature type="cross-link" description="N5-[4-(S-L-cysteinyl)-5-methyl-1H-imidazol-2-yl]-L-ornithine (Arg-Cys) (interchain with C-151 in KEAP1)" evidence="40">
<location>
<position position="135"/>
</location>
</feature>
<feature type="cross-link" description="N5-[4-(S-L-cysteinyl)-5-methyl-1H-imidazol-2-yl]-L-ornithine (Cys-Arg) (interchain with R-135 in KEAP1)" evidence="40">
<location>
<position position="151"/>
</location>
</feature>
<feature type="sequence variant" description="In a breast cancer sample; somatic mutation." id="VAR_036084" evidence="23">
<original>C</original>
<variation>Y</variation>
<location>
<position position="23"/>
</location>
</feature>
<feature type="sequence variant" description="In a lung adenocarcinoma patient." id="VAR_032102" evidence="24">
<original>V</original>
<variation>F</variation>
<location>
<position position="167"/>
</location>
</feature>
<feature type="sequence variant" description="In a NSCLC cell line." id="VAR_032103" evidence="24">
<original>D</original>
<variation>H</variation>
<location>
<position position="236"/>
</location>
</feature>
<feature type="sequence variant" description="In a lung adenocarcinoma patient." id="VAR_032104" evidence="24">
<original>Q</original>
<variation>L</variation>
<location>
<position position="284"/>
</location>
</feature>
<feature type="sequence variant" description="In a NSCLC cell line; strongly reduces interaction with NFE2L2/NRF2 and reduces repression of NFE2L2/NRF2-dependent gene expression." id="VAR_032105" evidence="24">
<original>G</original>
<variation>C</variation>
<location>
<position position="333"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs1048289." id="VAR_032106" evidence="41">
<original>D</original>
<variation>N</variation>
<location>
<position position="349"/>
</location>
</feature>
<feature type="sequence variant" description="In a NSCLC cell line; dbSNP:rs777308626." id="VAR_032107" evidence="24">
<original>G</original>
<variation>S</variation>
<location>
<position position="350"/>
</location>
</feature>
<feature type="sequence variant" description="In a lung adenocarcinoma cell line; also in NSCLC cell lines; may be a polymorphism; strongly reduces interaction with NFE2L2/NRF2 and reduces repression of NFE2L2/NRF2-dependent gene expression; dbSNP:rs1397945617." id="VAR_032108" evidence="20">
<original>G</original>
<variation>C</variation>
<location>
<position position="364"/>
</location>
</feature>
<feature type="sequence variant" description="In a lung adenocarcinoma patient; somatic mutation; strongly reduces interaction with NFE2L2/NRF2 and reduces repression of NFE2L2/NRF2-dependent gene expression." id="VAR_032109" evidence="20">
<original>G</original>
<variation>C</variation>
<location>
<position position="430"/>
</location>
</feature>
<feature type="sequence variant" description="In a breast cancer sample; somatic mutation." id="VAR_036085" evidence="23">
<original>A</original>
<variation>V</variation>
<location>
<position position="522"/>
</location>
</feature>
<feature type="mutagenesis site" description="Reduced formation of a high-molecular mass KEAP1 molecule when methylglyoxal accumulates." evidence="40">
<original>R</original>
<variation>A</variation>
<location>
<position position="15"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolished interaction with NFE2L2/NRF2; when associated with 161-A-A-162." evidence="16">
<original>VSIEG</original>
<variation>ASAEA</variation>
<location>
<begin position="123"/>
<end position="127"/>
</location>
</feature>
<feature type="mutagenesis site" description="Increases ubiquitination and proteolytic degradation." evidence="15">
<original>IEG</original>
<variation>AAA</variation>
<location>
<begin position="125"/>
<end position="127"/>
</location>
</feature>
<feature type="mutagenesis site" description="Reduced formation of a high-molecular mass KEAP1 molecule when methylglyoxal accumulates." evidence="40">
<original>R</original>
<variation>A</variation>
<location>
<position position="135"/>
</location>
</feature>
<feature type="mutagenesis site" description="Substitution with a small side chain that prevents covalent modification by an electrophile; promotes constitutive ubiquitination of NFE2L2/NRF2 and subsequent repression of phase 2 detoxifying enzymes. Resistance of ubiquitination of PGAM5 to inhibition by oxidative stress and sulforaphane. Impaired interaction with CUL3. Reduced formation of a high-molecular mass KEAP1 molecule when methylglyoxal accumulates." evidence="13 18 25 27 30 39 40">
<original>C</original>
<variation>S</variation>
<variation>N</variation>
<variation>D</variation>
<variation>L</variation>
<location>
<position position="151"/>
</location>
</feature>
<feature type="mutagenesis site" description="Substitution with a bulky side chain that mimicks covalent modification by an electrophile; prevents ubiquitination and degradation of NFE2L2/NRF2, leading to constitutive activation of NFE2L2/NRF2 and subsequent expression of phase 2 detoxifying enzymes." evidence="30 36">
<original>C</original>
<variation>W</variation>
<variation>Y</variation>
<location>
<position position="151"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolished interaction with NFE2L2/NRF2; when associated with 123-A--A-127." evidence="16">
<original>MY</original>
<variation>AA</variation>
<location>
<begin position="161"/>
<end position="162"/>
</location>
</feature>
<feature type="mutagenesis site" description="Increases ubiquitination and proteolytic degradation." evidence="15">
<original>YQI</original>
<variation>AAA</variation>
<location>
<begin position="162"/>
<end position="164"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes repression of NFE2L2/NRF2-dependent gene expression. Slows down degradation of NFE2L2/NRF2." evidence="13">
<original>C</original>
<variation>S</variation>
<location>
<position position="273"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes repression of NFE2L2/NRF2-dependent gene expression. Slows down degradation of NFE2L2/NRF2." evidence="13">
<original>C</original>
<variation>S</variation>
<location>
<position position="288"/>
</location>
</feature>
<feature type="mutagenesis site" description="Loss of export from nucleus; when associated with A-310." evidence="17">
<original>L</original>
<variation>A</variation>
<location>
<position position="308"/>
</location>
</feature>
<feature type="mutagenesis site" description="Loss of export from nucleus; when associated with A-308." evidence="17">
<original>L</original>
<variation>A</variation>
<location>
<position position="310"/>
</location>
</feature>
<feature type="mutagenesis site" description="Loss of interaction with NFE2L2/NRF2. Strongly reduces repression of NFE2L2/NRF2-dependent gene expression. Loss of interaction with PGAM5." evidence="22 25">
<original>Y</original>
<variation>A</variation>
<location>
<position position="334"/>
</location>
</feature>
<feature type="mutagenesis site" description="Loss of interaction with NFE2L2/NRF2. Abolishes repression of NFE2L2/NRF2-dependent gene expression. Impaired interaction with SQSTM1/p62." evidence="22 31">
<original>R</original>
<variation>A</variation>
<location>
<position position="380"/>
</location>
</feature>
<feature type="mutagenesis site" description="Loss of interaction with NFE2L2/NRF2. Strongly reduces repression of NFE2L2/NRF2-dependent gene expression. Impaired interaction with SQSTM1/p62." evidence="22 31">
<original>N</original>
<variation>A</variation>
<location>
<position position="382"/>
</location>
</feature>
<feature type="mutagenesis site" description="Loss of interaction with NFE2L2/NRF2. Abolishes repression of NFE2L2/NRF2-dependent gene expression. Loss of interaction with PGAM5. Does not affect interaction with SQSTM1/p62." evidence="22 25 31">
<original>R</original>
<variation>A</variation>
<location>
<position position="415"/>
</location>
</feature>
<feature type="mutagenesis site" description="Loss of interaction with NFE2L2/NRF2. Abolishes repression of NFE2L2/NRF2-dependent gene expression. Does not affect interaction with SQSTM1/p62." evidence="22 31">
<original>H</original>
<variation>A</variation>
<location>
<position position="436"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes repression of NFE2L2/NRF2-dependent gene expression." evidence="22">
<original>F</original>
<variation>A</variation>
<location>
<position position="478"/>
</location>
</feature>
<feature type="mutagenesis site" description="Loss of interaction with NFE2L2/NRF2. Abolishes repression of NFE2L2/NRF2-dependent gene expression. Loss of interaction with PGAM5. Does not affect interaction with SQSTM1/p62." evidence="22 25 31">
<original>R</original>
<variation>A</variation>
<location>
<position position="483"/>
</location>
</feature>
<feature type="mutagenesis site" description="Loss of interaction with NFE2L2/NRF2. Strongly reduces repression of NFE2L2/NRF2-dependent gene expression. Abolishes interaction with SQSTM1/p62." evidence="22 31">
<original>Y</original>
<variation>A</variation>
<location>
<position position="525"/>
</location>
</feature>
<feature type="mutagenesis site" description="Loss of interaction with NFE2L2/NRF2. Strongly reduces repression of NFE2L2/NRF2-dependent gene expression. Loss of interaction with PGAM5. Abolishes interaction with SQSTM1/p62." evidence="22 25 31">
<original>Y</original>
<variation>A</variation>
<location>
<position position="572"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 4; BAG51647." ref="4" evidence="45">
<original>N</original>
<variation>S</variation>
<location>
<position position="504"/>
</location>
</feature>
<feature type="helix" evidence="8">
<location>
<begin position="59"/>
<end position="72"/>
</location>
</feature>
<feature type="strand" evidence="8">
<location>
<begin position="79"/>
<end position="83"/>
</location>
</feature>
<feature type="strand" evidence="6">
<location>
<begin position="86"/>
<end position="88"/>
</location>
</feature>
<feature type="strand" evidence="8">
<location>
<begin position="91"/>
<end position="95"/>
</location>
</feature>
<feature type="helix" evidence="8">
<location>
<begin position="97"/>
<end position="103"/>
</location>
</feature>
<feature type="helix" evidence="8">
<location>
<begin position="105"/>
<end position="111"/>
</location>
</feature>
<feature type="strand" evidence="8">
<location>
<begin position="121"/>
<end position="125"/>
</location>
</feature>
<feature type="helix" evidence="8">
<location>
<begin position="130"/>
<end position="142"/>
</location>
</feature>
<feature type="helix" evidence="8">
<location>
<begin position="149"/>
<end position="151"/>
</location>
</feature>
<feature type="helix" evidence="8">
<location>
<begin position="152"/>
<end position="161"/>
</location>
</feature>
<feature type="helix" evidence="8">
<location>
<begin position="165"/>
<end position="177"/>
</location>
</feature>
<feature type="turn" evidence="9">
<location>
<begin position="181"/>
<end position="183"/>
</location>
</feature>
<feature type="helix" evidence="9">
<location>
<begin position="184"/>
<end position="194"/>
</location>
</feature>
<feature type="helix" evidence="9">
<location>
<begin position="199"/>
<end position="202"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="327"/>
<end position="331"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="334"/>
<end position="338"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="342"/>
<end position="345"/>
</location>
</feature>
<feature type="turn" evidence="1">
<location>
<begin position="347"/>
<end position="349"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="352"/>
<end position="354"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="362"/>
<end position="364"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="366"/>
<end position="370"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="373"/>
<end position="377"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="380"/>
<end position="383"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="386"/>
<end position="389"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="393"/>
<end position="396"/>
</location>
</feature>
<feature type="turn" evidence="1">
<location>
<begin position="398"/>
<end position="400"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="403"/>
<end position="405"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="417"/>
<end position="421"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="424"/>
<end position="428"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="440"/>
<end position="444"/>
</location>
</feature>
<feature type="turn" evidence="1">
<location>
<begin position="445"/>
<end position="448"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="449"/>
<end position="452"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="464"/>
<end position="468"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="471"/>
<end position="475"/>
</location>
</feature>
<feature type="strand" evidence="10">
<location>
<begin position="480"/>
<end position="483"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="487"/>
<end position="491"/>
</location>
</feature>
<feature type="turn" evidence="1">
<location>
<begin position="492"/>
<end position="495"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="496"/>
<end position="499"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="511"/>
<end position="515"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="518"/>
<end position="522"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="527"/>
<end position="530"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="534"/>
<end position="538"/>
</location>
</feature>
<feature type="turn" evidence="1">
<location>
<begin position="539"/>
<end position="542"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="543"/>
<end position="547"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="558"/>
<end position="562"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="565"/>
<end position="569"/>
</location>
</feature>
<feature type="strand" evidence="7">
<location>
<begin position="574"/>
<end position="577"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="580"/>
<end position="585"/>
</location>
</feature>
<feature type="turn" evidence="1">
<location>
<begin position="586"/>
<end position="589"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="590"/>
<end position="596"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="605"/>
<end position="609"/>
</location>
</feature>
<evidence key="1" type="ECO:0000244">
<source>
<dbReference type="PDB" id="1ZGK"/>
</source>
</evidence>
<evidence key="2" type="ECO:0000244">
<source>
<dbReference type="PDB" id="2FLU"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000244">
<source>
<dbReference type="PDB" id="4CXI"/>
</source>
</evidence>
<evidence key="4" type="ECO:0000244">
<source>
<dbReference type="PDB" id="4CXJ"/>
</source>
</evidence>
<evidence key="5" type="ECO:0000244">
<source>
<dbReference type="PDB" id="4CXT"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000244">
<source>
<dbReference type="PDB" id="5DAD"/>
</source>
</evidence>
<evidence key="7" type="ECO:0000244">
<source>
<dbReference type="PDB" id="5F72"/>
</source>
</evidence>
<evidence key="8" type="ECO:0000244">
<source>
<dbReference type="PDB" id="5GIT"/>
</source>
</evidence>
<evidence key="9" type="ECO:0000244">
<source>
<dbReference type="PDB" id="5NLB"/>
</source>
</evidence>
<evidence key="10" type="ECO:0000244">
<source>
<dbReference type="PDB" id="6HWS"/>
</source>
</evidence>
<evidence key="11" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="Q9Z2X8"/>
</source>
</evidence>
<evidence key="12" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00037"/>
</source>
</evidence>
<evidence key="13" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="14585973"/>
</source>
</evidence>
<evidence key="14" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15379550"/>
</source>
</evidence>
<evidence key="15" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15572695"/>
</source>
</evidence>
<evidence key="16" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15601839"/>
</source>
</evidence>
<evidence key="17" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15657435"/>
</source>
</evidence>
<evidence key="18" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15983046"/>
</source>
</evidence>
<evidence key="19" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16006525"/>
</source>
</evidence>
<evidence key="20" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16507366"/>
</source>
</evidence>
<evidence key="21" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16687406"/>
</source>
</evidence>
<evidence key="22" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16888629"/>
</source>
</evidence>
<evidence key="23" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16959974"/>
</source>
</evidence>
<evidence key="24" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17020408"/>
</source>
</evidence>
<evidence key="25" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17046835"/>
</source>
</evidence>
<evidence key="26" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17127771"/>
</source>
</evidence>
<evidence key="27" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18251510"/>
</source>
</evidence>
<evidence key="28" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18387606"/>
</source>
</evidence>
<evidence key="29" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19424503"/>
</source>
</evidence>
<evidence key="30" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19489739"/>
</source>
</evidence>
<evidence key="31" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20452972"/>
</source>
</evidence>
<evidence key="32" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20495340"/>
</source>
</evidence>
<evidence key="33" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="23274085"/>
</source>
</evidence>
<evidence key="34" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="24089205"/>
</source>
</evidence>
<evidence key="35" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="24630991"/>
</source>
</evidence>
<evidence key="36" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="24896564"/>
</source>
</evidence>
<evidence key="37" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="26517842"/>
</source>
</evidence>
<evidence key="38" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="28380357"/>
</source>
</evidence>
<evidence key="39" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="29590092"/>
</source>
</evidence>
<evidence key="40" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="30323285"/>
</source>
</evidence>
<evidence key="41" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8590280"/>
</source>
</evidence>
<evidence key="42" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="14585973"/>
</source>
</evidence>
<evidence key="43" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="8590280"/>
</source>
</evidence>
<evidence key="44" type="ECO:0000303">
<source ref="1"/>
</evidence>
<evidence key="45" type="ECO:0000305"/>
<evidence key="46" type="ECO:0000312">
<source>
<dbReference type="HGNC" id="HGNC:23177"/>
</source>
</evidence>
<sequence length="624" mass="69666" checksum="CE180F3897BB8C97" modified="2007-05-01" version="2">MQPDPRPSGAGACCRFLPLQSQCPEGAGDAVMYASTECKAEVTPSQHGNRTFSYTLEDHTKQAFGIMNELRLSQQLCDVTLQVKYQDAPAAQFMAHKVVLASSSPVFKAMFTNGLREQGMEVVSIEGIHPKVMERLIEFAYTASISMGEKCVLHVMNGAVMYQIDSVVRACSDFLVQQLDPSNAIGIANFAEQIGCVELHQRAREYIYMHFGEVAKQEEFFNLSHCQLVTLISRDDLNVRCESEVFHACINWVKYDCEQRRFYVQALLRAVRCHSLTPNFLQMQLQKCEILQSDSRCKDYLVKIFEELTLHKPTQVMPCRAPKVGRLIYTAGGYFRQSLSYLEAYNPSDGTWLRLADLQVPRSGLAGCVVGGLLYAVGGRNNSPDGNTDSSALDCYNPMTNQWSPCAPMSVPRNRIGVGVIDGHIYAVGGSHGCIHHNSVERYEPERDEWHLVAPMLTRRIGVGVAVLNRLLYAVGGFDGTNRLNSAECYYPERNEWRMITAMNTIRSGAGVCVLHNCIYAAGGYDGQDQLNSVERYDVETETWTFVAPMKHRRSALGITVHQGRIYVLGGYDGHTFLDSVECYDPDTDTWSEVTRMTSGRSGVGVAVTMEPCRKQIDQQNCTC</sequence>
</entry>
<copyright>
Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
Distributed under the Creative Commons Attribution (CC BY 4.0) License
</copyright>
</uniprot>

